Vaccines, Blood & Biologics
-
RECOTHROM
STN: BL 125248
Proper Name: Thrombin, topical (Recombinant)
Tradename: RECOTHROM
Manufacturer: ZymoGenetics, Inc, License #1758
Indication: An aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques is ineffective or impractical
-
-
-
Related Information
FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.- Press Release: FDA Approves First Clotting Solution Made Using Recombinant DNA Technology
-
Contact FDA
(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-